Brokerage Firm Rating Update on Mednax Inc (MD)

Mednax Inc (MD) : The consensus on Mednax Inc (MD) based on 11 analyst recommendation on the company stock is 2, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 5 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 1 analyst believes that the stock is a Buy, which can produce decent returns in the future. 5 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.

Mednax Inc (MD) : Average target price received by Mednax Inc (MD) is $77.14 with an expected standard deviation of $6.26. The most aggressive target on the stock is $90, whereas the most downbeat target is $70. 7 financial analysts are currently covering the stock.


For the current week, the company shares have a recommendation consensus of Buy. Also, Equity analysts at the Brokerage firm Jefferies maintains its rating on Mednax Inc (NYSE:MD). The rating major has initiated the coverage with buy rating on the shares. The Analysts at Jefferies lowers the price target from $80 per share to $75 per share. The rating by the firm was issued on August 26, 2016.

Mednax Inc (NYSE:MD): The stock opened at $66.87 and touched an intraday high of $67.76 on Wednesday. During the day, the stock corrected to an intraday low of $66.76, however, the bulls stepped in and pushed the price higher to close in the green at $67.15 with a gain of 0.39% for the day. The total traded volume for the day was 989,934. The stock had closed at $66.89 in the previous trading session.

MEDNAX, Inc. (MEDNAX) is a provider of physician services, including newborn, maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units, primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals, 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists and pediatric surgeons.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.